Clinical Trial Update: Dolutegravir Plus Lamivudine Dual Therapy in Treatment Naïve HIV-1 Patients [Phase 2]

View source ↗

Summary

Phase 2 results for dolutegravir plus lamivudine dual therapy in treatment-naïve HIV-1 infection were posted after the trial completed. The study evaluated the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Epivir (Lamivudine)
• Tivicay (dolutegravir)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED | Results posted: 2018-03-30